On the occasion of World Health Day, experts have raised concerns that urban India continues to show significant hesitation toward the Human Papillomavirus (HPV) vaccine, despite growing awareness and government efforts to promote it.
The HPV vaccine is a critical preventive tool against cervical cancer, one of the most common cancers affecting women in India. The government recently launched a nationwide vaccination drive targeting adolescent girls, aiming to reduce the country’s high disease burden and long-term mortality rates.
However, uptake in urban areas remains slower than expected. Experts attribute this reluctance to a mix of misinformation, cultural discomfort, and lack of clear communication. Many parents are still uncertain about the vaccine’s safety, necessity, and long-term effects, even though it has been widely used and studied globally.
A major factor driving fear is the stigma associated with HPV being a sexually transmitted infection. Conversations around sexual health are often avoided in families, leading to confusion and delayed decision-making. This silence allows myths and misconceptions to spread more easily, particularly through social media and informal networks.
Doctors also point out that urban populations, despite better access to healthcare, tend to overanalyse risks and are more exposed to conflicting information online. This can result in vaccine hesitancy, even among educated families.
Another issue is the lack of strong recommendations from healthcare providers. Experts stress that when doctors actively counsel families, acceptance rates improve significantly. Without this guidance, many parents choose to delay or skip vaccination altogether.
The consequences of this hesitation are serious. India accounts for a substantial share of global cervical cancer cases and deaths, with thousands of women affected every year. Since the disease develops slowly and is largely preventable, early vaccination plays a crucial role in reducing future health risks.
To address these concerns, health professionals are calling for stronger awareness campaigns, open conversations about sexual health, and better engagement between doctors, schools, and parents. They emphasise that normalising discussions around preventive care and improving trust in vaccines are essential to increasing uptake.
Overall, while India has taken a major step forward with its HPV vaccination programme, overcoming fear and misinformation—especially in urban areas—remains key to ensuring its success and protecting future generations.
